$ACGX News: Alliance Creative Group (ACGX) Reports Total

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
107
$ACGX News: Alliance Creative Group (ACGX) Reports Total Revenue of $2,613,997 for First Quarter of 2021 with Net Income of $256,799

2021 Quarterly Net Income increased by $237,206 compared to Q1 2020


CHICAGO, May 14, 2021 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ending March 31, 2021.

Revenues for the quarter ending March 31, 2021 ("Q1 2021" were $2,613,997

Gross Profits for the quarter ending March 31, 2021 ("Q1 2021" were $550,944

Net Income for the quarter ending March 31, 2021 ("Q1 2021" were $256,799

The total assets on the Balance Sheet for the Alliance Creative Group as of 3/31/21 were $3,587,857.

The total outstanding common shares as of March 31, 2021 ("Q1 2021" were 1,639,611 with 1,149,023 of those shares in the float.

The Company ended the quarter and year with ($7,257) Cash on hand.

Total Stockholder Equity as of 03/31/21 was $1,532,890

The full financial statement, balance sheet, statement of operations, cash flow statement, and disclosure statements are posted on the OTC Market Company website at www.OTCmarkets.com under the stock symbol ACGX in the section for filings and disclosure and on www.ACGX.us in the investor relations section.

Steve St. Louis, CEO of the Alliance Creative Group, Inc., said, "The first Quarter of 2021 ended with our largest Net Income in a long time, mostly due to the PPP forgiveness, but we were able to pay down more liabilities to get us in a stronger position for the future. We will continue to evaluate all our options and ideas to hopefully maintain and improve the positive progress for 2021 and beyond."

About Alliance Creative Group, Inc.

Alliance Creative Group, Inc. (Stock Symbol: ACGX) is a Packaging Solutions Company focused on Retail Packaging and Packaging Management. ACG helps its clients from initial concept and packaging development through final production and managed inventory solutions. The core business has been around since 1997. ACG currently focuses mostly on providing solutions for flexible and clear packaging, folding cartons, vendor managed inventory supply chain services and fulfillment. Additional services include but are not limited to corrugated boxes, commercial printing, labels, and other products and services related to the printing or packaging of consumer products. ACG's team includes experts to provide high-quality packaging and printed products. The ACG experience includes very hands-on operational support out of 6 different warehouse locations and several national and international manufacturing partners. ACG provides customer support during the entire product process or cycle including but not limited to creating, warehousing, delivering, and replenishing their packaging products For more information, visit http://www.AllianceCreativeGroup.com or http://www.ACGX.us.

About PeopleVine

PeopleVine is a consolidated platform that allows businesses to build more personal relationships with their customers at scale. PeopleVine solves the problem businesses have creating and managing holistic relationships with their customers without using multiple products that only support a portion of the relationship building activities. PeopleVine seamlessly brings together the tools needed to market, sell, and operate a business with streamline efficiencies in a customer engagement suite and enables businesses to make data informed decisions to help generate revenue growth.

We are committed to being the most essential and adaptive SaaS engagement platform for companies that take a customer centric approach to business.

For more information www.PeopleVine.com

This news release contains forward-looking statements as defined by the bespeaks-caution doctrine. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Investor Relations and Media Contact

1-847-885-1800

Info@ACGemail.com

Cision View original content:http://www.prnewswire.com/news-releases/alliance-creative-group-acgx-reports-total-revenue-of-2-613-997-for-first-quarter-of-2021-with-net-income-of-256-799--301291364.html

SOURCE Alliance Creative Group, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 40

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Raytron Dominates Global Thermal Imaging Market in 2026

Updated Category News Views 106

Raytron's Market Supremacy: By the Numbers If you're looking at the thermal imaging sector and wondering what's what, take a clue from Raytron. This outfit isn't just playing the game—it's running the show with a staggering 30% of the global market in 2025. That's right, they hold the medal for leading global shipments in thermal imaging, and unlike many industries...

Continue Reading
Asphalt Additives Market Set for $7.07B Boom by 2031

Updated Category News Views 65

Asphalt Additives: A Lucrative Growth Path Let me tell you, the asphalt additives market isn't just sticking to the roads; it's rolling out real potential. Heading for a $7.07B finish line by 2031 with a steady pace of 7.3% CAGR, it's a road worth staking your claims on. The underlying story? It's more than just laying tar. Pavement to Profit: Key Drivers The asphalt...

Continue Reading
Pearl Meyer Leaders Grab NACD's Coveted Governance Honor

Updated Category News Views 26

NACD Recognition for Governance Grit Some folks just know how to steer a ship, and that's exactly what Pearl Meyer's Matt Turner and Jannice Koors have been doing. This year, they made it onto the NACD's 2026 Directorship 100 list, swinging as heavy hitters in the Governance Professionals category. It's not just another day at the office when you're honored by the...

Continue Reading
Epson Unveils Early Black Friday Tech Deals

Updated Category News Views 69

Diving Headfirst into Holiday Tech Splurging The holiday hustle is upon us, folks, and Epson's stepping up with early Black Friday deals that'll have tech heads scrambling. They’re cutting prices up to $250 on their swanky home lineup—projectors, printers, scanners, you name it. This ain't just about making someone else smile, though; it's about the sweet spot where...

Continue Reading
Doximity's Legal Woes: Class Action Deadline Looms

Updated Category News Views 15

The Truth Behind Doximity's Promises The brass tacks of investing often boil down to trust—a commodity that's now in short supply over at Doximity, Inc. (NYSE: DOCS). Investors have been left hanging after promises of lucrative engagement signals turned out to be a mere pipe dream. Levi & Korsinsky, LLP sounds the alarm on what's shaping up to be a high-stakes class...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading
Peanuts and Diabetes: A Surprising Health Link

Updated Category News Views 68

A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...

Continue Reading
Terra-Gen's $950M Lockhart Facility Powers California

Updated Category News Views 128

A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...

Continue Reading
Defense Contractors Push Forward Amid Indictments

Updated Category News Views 18

The Big Names Hold Steady Defense contractors are showing off their shiny earnings just as some disturbing headlines shake things up. It's like they're putting their best foot forward to steady the ship while the waters get choppy with terrorism charges and all sorts of geopolitical noise. Follow the smart money to see where the true bets are being placed—it all unfolds...

Continue Reading

Top 5 Most Recently Viewed Articles

Twilio's Q4 Results Spark Diverse Analyst Reactions

Updated Category News Views 232

Twilio Inc Fourth Quarter Overview Twilio Inc reported notable financial results for the fourth quarter, capturing the attention of several analysts within the market. The company’s performance has sparked diverse reactions, particularly regarding its future guidance and the evolving role of artificial intelligence within its operations. Market Response to Q4 Earnings...

Continue Reading
FHLBank Indianapolis Dividends for Second Quarter of 2025

Updated Category News Views 180

FHLBank Indianapolis Declares Second Quarter Dividends FHLBank Indianapolis recently announced its second quarter dividends for 2025, detailing robust financial strategies and growth, as reflected in the declared dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock. These dividends have been set at annualized rates of 9.50% and 4.50%,...

Continue Reading
Neurogen Biomarking Partners with Quanterix for Alzheimer's Testing

Updated Category News Views 255

Revolutionizing Alzheimer's Detection with Neurogen Biomarking Neurogen Biomarking is making significant strides in the healthcare landscape by introducing a pioneering blood test aimed at the early detection of Alzheimer's disease and Mild Cognitive Impairment (MCI). This innovative approach leverages advanced biomarker technology developed by Quanterix Corporation,...

Continue Reading
Kepler Robotics Launches Innovative Humanoid Robot for Industries

Updated Category News Views 296

Revolutionizing Industries with the K2 Bumblebee Shanghai Kepler Robotics Co., Ltd has excitedly announced the commencement of mass production of its K2 "Bumblebee" model, confirming that the world's first commercially available hybrid-architecture humanoid robot is now shipping to eager customers. Milestone in Humanoid Robotics This significant development not only marks...

Continue Reading
Syntara Limited Reveals Groundbreaking Data in Myelofibrosis Trials

Updated Category News Views 259

Positive Interim Data from Syntara's Clinical Trials Syntara Limited, known for its innovative approach in drug development, has unveiled promising interim data concerning its ongoing Phase 2 study of SNT-5505. This clinical trial focuses on myelofibrosis, a complex bone marrow disorder that often leads to severe health complications. Details of the Clinical Trial The...

Continue Reading